Paloma Partners Management CO Durect Corp Transaction History

Paloma Partners Management CO

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$1.69 - $3.8 $400,567 - $900,683	-237,022 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$0.61 - $2.21 $285,466 - $1.03 Million	-467,978 Reduced 66.38%	237,022 $436,000
Q2 2019 Aug 14, 2019	BUY	$0.51 - $0.86 $359,550 - $606,300	705,000 New	705,000 $460,000

593K

Ticker DRRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 227,794,000
Market Cap $255M
Description
DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogeno...

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

Stay updated on Paloma Partners Management CO with notifications on news.